journal article·2022-04-26

Alternatingly Amphiphilic Antimicrobial Oligoguanidines: Structure–Property Relationship and Usage as the Coating Material with Unprecedented Hemocompatibility

Zhiyong Chen, Wanqi Zhang, Yajie Chen, Yingjie Wang, Silei Bai, Qingyun Cai, Huangsheng Pu, Zuyong Wang, Xinxin Feng, Yugang Bai

Chemistry of Materials· Volume 34· Issue 8
Publisher page

Abstract

With the emergence of antibiotic resistance in recent years, the combat against bacteria is becoming more difficult and critical in human healthcare. In addition to the development of new chemical entities and derivatives of antibiotics and disinfectants, the antimicrobial surface is recognized as a potential way to prevent healthcare-associated infections, particularly those caused by medical devices such as implants and various catheters. However, traditional ways of engineering antimicrobial surfaces using coated metal nanostructures or blended-in antibiotics inevitably face the problem of metal ion or antibiotic leakage, leading to surface deactivation, toxicity, and antibiotic resistance. A new strategy developed in recent years involves the use of coated cationic antimicrobial polymers, which serve as resistance-resistant, surface-anchored antibacterial agents, but they also usually come with hemolytic activity resulting from their membrane-disrupting-type mechanism of action. In this report, we show that the combinatorial approach can be highly useful for the selection of alternatingly amphiphilic oligomers, which are essentially molecular nanorods as revealed by molecular dynamic simulations. The combinatorial process allowed the structure–property relationship of these molecular nanorods to be revealed and yielded oligoguanidine hit with high antimicrobial activity, fast killing kinetics, and extremely low hemolytic activity through assay screening. We demonstrate that the covalent conjugation of such a prescreened oligoguanidine nanorod to glass slides or polycaprolactone films could produce antimicrobial surfaces with excellent performance. A catheter prototype made using such a modified polycaprolactone film could transport bacteria-contaminated liquid, efficiently removing all bacteria without causing lysis of red blood cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial agents and applications · Pharmaceutical and Antibiotic Environmental Impacts · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Chem-/Bio-Sensing and Chemometrics, School of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan 410082, China

College of Materials Science and Engineering, Hunan University, Changsha, Hunan 410082, China

Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518055, China

College of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha, Hunan 410073, China

Funding

Natural Science Foundation of?Hunan Province · Science, Technology and Innovation Commission of Shenzhen Municipality · National Natural Science Foundation of China · Advanced Interdisciplinary Program of the College of Advanced Interdisciplinary Studies of NUDT

References (53)

Show source-provided references
1. 10.1016/s1473-3099(11)70316-410.1016/s1473-3099(11)70316-4 ↗
2. 10.1038/d41586-020-02884-310.1038/d41586-020-02884-3 ↗
3. 10.1038/495141a10.1038/495141a ↗
4. 10.2147/idr.s17386710.2147/idr.s173867 ↗
5. Jonas, O. B.; Irwin, A.; Berthe, F. C. J.; Le Gall, F. G.; Marquez, P. V. Drug-resistant infections: a threat to our economic future (Vol. 2): final report (English). HNP/Agriculture Global Antimicrobial Resistance Initiative; World Bank Group: Washington D. C., 2017. http://documents.worldbank.org/curated/en/323311493396993758/final-report (accessed March 18, 2022).
6. No Time to Wait: Securing the future from drug-resistant Infections. Interagency Coordination Group on Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2019. https://www.who.int/publications/i/item/no-time-to-wait-securing-the-future-from-drug-resistant-infections (accessed March 18, 2022).
7. 10.1016/s1473-3099(13)70318-910.1016/s1473-3099(13)70318-9 ↗
8. 10.1016/j.vetmic.2014.02.03510.1016/j.vetmic.2014.02.035 ↗
9. 10.1136/bmj.f149310.1136/bmj.f1493 ↗
10. 10.1016/j.tibtech.2011.01.00710.1016/j.tibtech.2011.01.007 ↗
11. 10.1086/51454510.1086/514545 ↗
12. 10.1186/1744-8603-9-4810.1186/1744-8603-9-48 ↗
13. 10.1038/s41570-021-00313-110.1038/s41570-021-00313-1 ↗
14. 10.1016/j.mib.2019.10.00810.1016/j.mib.2019.10.008 ↗
15. 10.1016/j.tim.2018.12.01010.1016/j.tim.2018.12.010 ↗
16. 10.1038/nature1704210.1038/nature17042 ↗
17. 10.1002/adma.20100121510.1002/adma.201001215 ↗
18. 10.1016/j.biomaterials.2013.07.08910.1016/j.biomaterials.2013.07.089 ↗
19. 10.1016/j.tibtech.2013.01.01710.1016/j.tibtech.2013.01.017 ↗
20. 10.1016/j.tibtech.2015.09.00210.1016/j.tibtech.2015.09.002 ↗
21. 10.1086/66877010.1086/668770 ↗
22. 10.1099/jmm.0.00003210.1099/jmm.0.000032 ↗
23. 10.1038/s41579-018-0019-y10.1038/s41579-018-0019-y ↗
24. 10.1038/nrmicro343210.1038/nrmicro3432 ↗
25. 10.1002/pola.2844610.1002/pola.28446 ↗
26. 10.3390/polym401004610.3390/polym4010046 ↗
27. 10.1021/acs.biomac.8b0045810.1021/acs.biomac.8b00458 ↗
28. 10.1016/s0005-2736(99)00200-x10.1016/s0005-2736(99)00200-x ↗
29. 10.1073/pnas.150789311210.1073/pnas.1507893112 ↗
30. 10.1016/j.biomaterials.2021.12085810.1016/j.biomaterials.2021.120858 ↗
31. 10.1126/sciadv.abc991710.1126/sciadv.abc9917 ↗
32. 10.1038/srep2312110.1038/srep23121 ↗
33. 10.1016/j.jmst.2020.08.02110.1016/j.jmst.2020.08.021 ↗
34. 10.1002/marc.20190026810.1002/marc.201900268 ↗
35. 10.1038/nm114510.1038/nm1145 ↗
36. 10.1586/eri.13.1210.1586/eri.13.12 ↗
37. 10.1155/2016/247506710.1155/2016/2475067 ↗
38. 10.1128/cmr.00181-1910.1128/cmr.00181-19 ↗
39. Tacconelli, E.; Magrini, N. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotic; World Health Organization: Geneva, Switzerland, 2017. https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf (accessed March 18, 2022).
40. 10.1021/ja500367u10.1021/ja500367u ↗
41. 10.1007/s10822-005-8694-y10.1007/s10822-005-8694-y ↗
42. 10.1002/macp.20070041810.1002/macp.200700418 ↗
43. 10.1021/ja045664d10.1021/ja045664d ↗
44. 10.1021/ja801662y10.1021/ja801662y ↗
45. 10.1038/3501250010.1038/35012500 ↗
46. 10.1016/s1473-3099(15)00424-710.1016/s1473-3099(15)00424-7 ↗
47. 10.1128/MMBR.00016-1010.1128/MMBR.00016-10 ↗
48. 10.1271/bbb.61.56510.1271/bbb.61.565 ↗
49. 10.1056/nejm19980820339080610.1056/nejm199808203390806 ↗
50. 10.1002/jbm.a.3489910.1002/jbm.a.34899 ↗
51. 10.1039/c4tb00522h10.1039/c4tb00522h ↗
52. 10.1097/00003246-199905000-0002010.1097/00003246-199905000-00020 ↗
53. 10.1038/nrmicro.2017.9910.1038/nrmicro.2017.99 ↗